Citrate buffered VEGF antagonist formulations Grant US-11806398-B2 United States of America 07 Nov 2023
VEGF antagonist formulations suitable for intravitreal administration Grant US-11732024-B2 United States of America 22 Aug 2023
Formulations of VEG antagonist fusion proteins and method of manufacturing them Grant US-10857231-B2 United States of America 08 Dec 2020
Method of manufacturing VEGF antagonist fusion proteins Application US-10406226-B2 United States of America 10 Sep 2019